Cutler Group LP Avadel Pharmaceuticals PLC Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$2.57 - $7.31 $10,280 - $29,240	-4,000 Reduced 97.56%	100 $0
Q2 2022 Aug 04, 2022	SELL	$1.07 - $6.95 $13,910 - $90,350	-13,000 Reduced 76.02%	4,100 $21,000
Q1 2022 Apr 14, 2022	BUY	$5.46 - $8.29 $59,514 - $90,360	10,900 Added 175.81%	17,100 $54,000
Q1 2020 May 07, 2020	BUY	$4.06 - $10.64 $25,171 - $65,968	6,200 New	6,200 $13,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.